GCGM
MAZE

General Catalyst Group Management’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

General Catalyst Group Management’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$12.7M Hold
1,035,910
– – 0.3% 7
2025
Q1 		$11.4M Buy
+1,035,910
New +$11.4M 1.29% 8